Loading...
Please wait, while we are loading the content...
In-vitro Cytotoxicity studies of psidium guajava against Ehrlich ascites carcinoma cell lines
| Content Provider | Semantic Scholar |
|---|---|
| Author | Banu, Shakeera |
| Copyright Year | 2017 |
| Abstract | The Current research explains the in-vitro anticancer activity of psidium guajava plant extract against Ehrlich ascites carcinoma cell lines. The common guava tree (psidium guajava) is popular in an indigenous system of folk medicines. Traditionally Psidium guajava is used for the treatment of various ailments. Most scientific evidence examined the clinical efficacy of guava in treating gastrointestinal disorders. Other investigations examined antiamebic, antibiotic, antidiarrheic, antihyperglycemic, antimutagenic, antispasmodic, and sedative effects, as well as anticough and narcotic-like activities of the plant species. The current research described psidium guajava anticancer activity against Ehrlich ascites carcinoma cell lines. Ehrlich Ascites Carcinoma cells resembles human tumors which are the most sensitive to chemotherapy due to the fact that they are undifferentiated and that they have a rapid growth rate. This study evaluated the anticancer activity of crude and fractionated extract of psidium guajava against Ehrlich ascites carcinoma cell lines in-vitro by using tryphan blue test and MTT assay. |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://www.discoveryjournals.org/science/current_issue/2015/A59.pdf |
| Alternate Webpage(s) | http://discoveryjournals.org/drugdiscovery/current_issue/2019/A10.pdf |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |